Skip to content
Abierto
Menu

Award notice

Pluvicto and Lutathera 5 Year BPA

HT941026AE002

Defense Health Agency (Dha), Defense Health Agency HCD West. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Novartis Pharmaceuticals Corporation

$5,000,000.00 on the award notice, January 29, 2026, contract HT941026AE002

Description

As published on SAM.gov.

Contract Award Pluvicto and Lutathera 5 Year BPA

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Novartis Pharmaceuticals Corporation
UEI
NG61ZA8TADW3
CAGE
04520
Vendor location
East Hanover, NJ
Contract
HT941026AE002
Obligated
$0.00, potential $5,000,000
Actions
2 between January 29, 2026 and February 9, 2026
Described as
BPA for Pluvicto and Lutathera Injection
Match
award number HT941026AE002 equals the contract number; same awarding office HT9410 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 29, 2026

    Award notice

    Awarded to Novartis Pharmaceuticals Corporation East Hanover for $5,000,000. SAM.gov, notice 91973de553e2439b928069cd4984864a

Points of contact

Also open from this buyer